(Q35598569)

9 August 2017

Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase (English)

1 reference

inflammatory bowel diseases

9 August 2017

0 references

author name string

Keiichi Mitsuyama

1

1 reference

9 August 2017

Nobuo Tomiyasu

2

1 reference

9 August 2017

Kosuke Takaki

3

1 reference

9 August 2017

Junya Masuda

4

1 reference

9 August 2017

Hiroshi Yamasaki

5

1 reference

9 August 2017

Kotaro Kuwaki

6

1 reference

9 August 2017

Teiko Takeda

7

1 reference

9 August 2017

Shigehiko Kitazaki

8

1 reference

9 August 2017

Osamu Tsuruta

9

1 reference

9 August 2017

Michio Sata

10

1 reference

9 August 2017

1 January 2006

1 reference

Mediators of Inflammation

9 August 2017

1 reference

9 August 2017

2006

1 reference

9 August 2017

26875

1 reference

9 August 2017

6

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

start time

1 January 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Boosting interleukin-10 production: therapeutic effects and mechanisms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Structural features of the interleukin-10 family of cytokines

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

IL-10 and its related cytokines for treatment of inflammatory bowel disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

27 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

27 July 2018

https://api.crossref.org/works/10.1155%2FMI%2F2006%2F26875

Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

IL-10 inhibits cytokine production by activated macrophages

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Inflammatory bowel disease (1)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Human soluble IL-6 receptor: its detection and enhanced release by HIV infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Bacterial toxin-induced cytokine production studied at the single-cell level

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Biological properties of interleukin 10.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Interleukin-10-deficient mice develop chronic enterocolitis

27 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2FMI%2F2006%2F26875

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2FMI%2F2006%2F26875

Pathogenesis of inflammatory bowel disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1775031

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

26 September 2018

1 reference

12 December 2020

Involvement of interleukin-4 and -10 in inflammatory bowel disease

1 reference

12 December 2020

Colonic Mucosal Interleukin-6 in Inflammatory Bowel Disease

1 reference

12 December 2020

Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10.

1 reference

12 December 2020

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification

1 reference

12 December 2020

Significance of interleukin-6 in patients with inflammatory bowel disease

1 reference

12 December 2020

A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease

1 reference

12 December 2020

Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease

1 reference

12 December 2020

Identifiers

DOI

10.1155/MI/2006/26875

1 reference

9 August 2017

1 reference

9 August 2017

1 reference